Recent Posts


FDA Approves Genentech’s Rozlytrek (entrectinib) for ROS1 Non-Small Cell Lung Cancer (NSCLC) and NTRK-Driven Tumors

August 16th, 2019|Hot Topics, News|

On August 15, 2019 the U.S. Food and Drug Administration approved Rozlytrek (entrectinib) for the treatment of patients with ROS1-positive, metastatic non-small cell lung cancer. It was also simultaneously approved for the treatment of patients with any solid tumor that is NTRK fusion-positive, following progression on other therapies. This [...]

Crisis and Relief: Reflections on World Lung Cancer Day

August 1st, 2019|Hot Topics|

World Lung Cancer Day is a time to remember that this disease remains a crisis around the globe. But is also a day to count the many ways that we’ve helped advance efforts on general awareness, early detection, research funding, innovative research, and support for patients and caregivers. Providing credible [...]

GO2 Foundation Presents 2019 Bonnie J. Addario Lectureship Award at ILCC

July 26th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer is pleased to announce that it presented Solange Peters, MD, PhD, with the 2019 Bonnie J. Addario Lectureship Award for her emphasis on groundbreaking biomarker research, improving access to care for lung cancer patients worldwide, and supporting the advancement of women in oncology. GO2 Foundation honored [...]

New Treatment Approved for Metastatic Small Cell Lung Cancer

June 18th, 2019|Hot Topics, News|

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option [...]

Early Screening Equals Early Diagnosis

June 18th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible [...]

Patient Voices Were Heard: Preserving Access to Life Saving Drug Therapies!

May 21st, 2019|Hot Topics, News|

On May 17, 2019, The Centers for Medicare & Medicaid Services (CMS) released the final Medicare Part D Rule, where they decided to preserve the original Six Protected Classes policy. GO2 Foundation for Lung Cancer (formerly Lung Cancer Alliance and the Bonnie J. Addario Lung Cancer Foundation) advocated to stop [...]

Join Our $20 Million By 2020 Campaign to Restore Full Funding for Lung Cancer Research!

May 9th, 2019|Hot Topics|

TAKE ACTION! Through consistent advocacy efforts, GO2­ Foundation (formerly Lung Cancer Alliance) established the Lung Cancer Research Program (LCRP) within the Congressionally Directed Medical Research Programs, administered by the Department of Defense with federal appropriations of $20 million in Fiscal Year (FY) 2009. LCRP has been underfunded the past [...]

Research Wins Big

May 7th, 2019|Hot Topics, News|

The GO2 Foundation for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care”—individuals and organizations that advance cancer care and work to improve the lives of those living [...]

New Resources for Healthcare Professionals Now Available!

May 1st, 2019|Hot Topics|

We had so many informative presentations at our 2018 Screening and Care Conference that we wanted to make sure everyone has access to this information. Check out top presentations on molecular testing and targeted therapy, improving access to care, the importance of a multidisciplinary conference for screening, and patient [...]

FDA Approves First-Line Treatment for NSCLC with PD-L1 Biomarker

April 12th, 2019|Hot Topics, News|

On April 11, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA) as a first-line treatment for patients with advanced NSCLC who have a score of 1% or higher on the PD-L1 biomarker test. The approval was based on KEYNOTE-042 trial which demonstrated statistically significant OS improvements for those randomized [...]

Priority Focus Renewed on Women’s Health Imperative – House and Senate Leaders Reintroduce Women and Lung Cancer Research and Preventive Services Act of 2019

April 10th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer hails bipartisan effort to accelerate progress to increase survivorship April 10, 2019 - Today the GO2 Foundation for Lung Cancer praises Senators Marco Rubio (R-FL), Dianne Feinstein (D-CA), Shelley Moore Capito (R-WV), and Joe Manchin (D-WV), and Representatives Brendan Boyle (D-PA), Brian Fitzpatrick (R-PA), Debbie Dingell [...]

Transforming Cancer Care

April 3rd, 2019|Hot Topics, News|

The landscape of cancer care is changing at a rapid pace with more research and treatment options than ever before. As exciting as these advancements are, the community standing by each cancer patient is equally important. Medical professionals, families, friends, advocates and organizations offering support services all play a crucial [...]

New First-Line Treatment Approved for Small Cell Lung Cancer

March 19th, 2019|Hot Topics, News|

On March 18, the U.S. Food and Drug Administration approved a combination of the immunotherapy atezolizumab (Tecentriq) along with standard chemotherapy (carboplatin and etoposide) for patients who are starting treatment for extensive stage small cell lung cancer. This is the first immunotherapy approved up front, as a first treatment, [...]

Register for the UNITED Portland Run/Walk, June 22!

February 26th, 2019|Events, Hot Topics|

This year, for the first time in Portland, two of the leading lung cancer organizations are joining forces to create one of the largest run/walk events for lung cancer on the west coast…because together we are stronger. Join Lung Cancer Alliance and Bonnie J. Addario Lung Cancer Foundation at Laurelhurst Park on Saturday, [...]

LCA Joins ACS CAN in Efforts to Protect Patient Access to Lifesaving Treatment

January 17th, 2019|Hot Topics, News|

Thursday, January 17 – Lung Cancer Alliance joins a long list of leading patient advocacy groups in support of American Cancer Society Cancer Action Network’s (ASC CAN) advertising campaign, urging the U.S. Administration and Congress not to limit patient access to lifesaving medications covered under Medicare, and to ensure [...]

New Year, New You!

January 3rd, 2019|Hot Topics|

Goodbye 2018, hello 2019! With the new year comes new opportunity to recommit to your health and well-being. If you’re part of the 41% of Americans looking to set a New Year resolution, we can help! Here are four worthy commitments to consider this year. FIND SUPPORT: Support in your [...]

Giving—Why Not?

December 12th, 2018|Hot Topics|

With the season of giving upon us, now is the perfect time to join the fight against lung cancer. Over 234,000 people were diagnosed with lung cancer this year, making it the leading cause of cancer death for both men and women across all ethnicities. You can help us [...]

New Combination Treatment Approved for Non-Small Cell Lung Cancer

December 7th, 2018|Hot Topics, News|

The Food and Drug Administration (FDA) approved atezolizumab (TECENTRIQ®), an immunotherapy drug, in combination with bevacizumab, paclitaxel, and carboplatin for the first-line treatment of patients with metastatic non-squamous, non-small cell lung cancer (NSq NSCLC) with no EGFR or ALK genomic tumor aberrations. This is the first four drug combination [...]

LCA partners with GRAIL, UCL, and ULCH on Newly Announced SUMMIT Study

December 4th, 2018|Hot Topics, News|

Monday, December 3, 2018 –Today, Lung Cancer Alliance, in collaboration with GRAIL, Inc., a healthcare company focused on the early detection of cancer, UCL (University College London) and University College London Hospitals National Health Service (NHS) Foundation Trust (UCLH) announced plans to initiate the SUMMIT study in early 2019. [...]

FDA Approves Targeted Therapy for Solid Tumors with NTRK Gene

November 27th, 2018|Hot Topics, News|

Tuesday, November 27, 2018 - The U.S. Food and Drug Administration (FDA) granted accelerated approval to larotrectinib (VITRAKVI, Loxo Oncology Inc. and Bayer) for adult and pediatric patients with advanced solid tumors, including lung cancer, that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance mutation. [...]

2018 Lung Cancer Support Group Facilitator Award

November 5th, 2018|Hot Topics, News|

Monday, November 5, 2018 -- Today, Lung Cancer Alliance presented the 2018 Lung Cancer Support Group Facilitator Award to Catherine Paykin, LCSW-R, who runs a support group at New York University Perlmutter Cancer Center. The Lung Cancer Support Group Facilitator Award recognizes the uncommon dedication of a support group facilitator. Members [...]

FDA Approves New Treatment for ALK+ NSCLC Patients

November 2nd, 2018|Hot Topics, News|

Friday, November 2, 2018 – Today the Food and Drug Administration (FDA) granted accelerated approval to lorlatinib (LORBRENA) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease [...]

LCA Partners with UAB Comprehensive Cancer Center to Help At-Risk, Underserved Communities

November 1st, 2018|Hot Topics, News|

Washington, D.C. - November 1, 2018 –Lung Cancer Alliance (LCA) today announced a $1.6M grant from the Bristol-Myers Squibb Foundation to partner with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center to establish the Alabama Lung Cancer Awareness, Screening and Education (ALCASE) program. The three-year effort will [...]

LCA Launches Nationwide Screening Awareness Campaign

October 31st, 2018|Hot Topics, News|

 “What About Your Lungs?” Campaign Urges Individuals At-Risk for Lung Cancer to Talk to Their Doctor About Life-Saving Screening Washington, DC [Wednesday, October 31, 2018]—Responding to the need to increase national awareness about lung cancer screening and encourage those at risk to talk with their doctor, Lung Cancer Alliance [...]

FDA Approves New Combination Treatment for NSCLC

October 31st, 2018|Hot Topics, News|

Tuesday, October 30, 2018 – Today the Food and Drug Administration (FDA) approved immunotherapy drug, pembrolizumab, also known as KEYTRUDA, in combination with chemotherapies, carboplatin, and either paclitaxel or nab-paclitaxel as a first-line treatment for patients with metastatic squamous non-small cell lung cancer (NSCLC). The results of the randomized [...]

LCA Urges CMS to Remove Barriers to Screening

October 25th, 2018|Hot Topics, News|

In a number of communications to the Centers for Medicare and Medicaid Services (CMS), Lung Cancer Alliance urged the national CMS office to 1) instruct all local Medicare contractors that lung cancer screening coverage is available in all settings including Independent Diagnostic Testing Facilities across the country and 2) [...]

Doing My Part

October 18th, 2018|Events, Hot Topics|

By Michelle McMahon My connection to lung cancer began when I was a teenager. I lost my mom to this disease just before her 53rd birthday. Some 33 years later I was handed the same lung cancer diagnosis in the form of Bronchoalveolar Carcinoma (BAC). I was 49 years [...]

New First-Line Treatment Approved for NSCLC with an EGFR Mutation

September 28th, 2018|Hot Topics, News|

Friday, September 28, 2018 – Today the Food and Drug Administration approved VIZIMPRO tablets (dacomitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with an EGFR (epidermal growth factor receptor) mutation. Approval was based on a randomized trial that showed a significant improvement in [...]

Highlights from World Conference on Lung Cancer

September 27th, 2018|Events, Hot Topics, News|

This week, the LCA team attended the 19th Annual World Conference on Lung Cancer (September 23-26, 2018) in Toronto, Canada. Jennifer C. King, PhD, Director of Science and Research, gives us the scoop on some of the research and treatment breakthroughs, and how they impact you! SCREENING REDUCES [...]

Passage of Historic Appropriations Bill Cements Funding for Lung Cancer Research

September 27th, 2018|Hot Topics, News|

Cancer and Health Programs See Gains in FY19 Budget Wednesday, September 26, 2018 – Today, Lung Cancer Alliance (LCA) acknowledges the historic passage of the combined Department of Defense (DOD) and Labor, Health and Human Services (LHHS) appropriations package by the House following approval by the Senate. The bill [...]

Trial Results Show Screening Significantly Reduces Lung Cancer Mortality Rates

September 25th, 2018|Hot Topics, News|

Washington, DC [September 25, 2018] – Lung Cancer Alliance (LCA) applauds the results of the Dutch-Belgium Lung Cancer Screening trial (NELSON) announced today in Toronto, Canada at the IASLC 19th World Conference on Lung Cancer. The NELSON study was a population-based, controlled trial that enrolled 15,792 individuals, who were [...]

LCA Survey Results Show Unmet Emotional Needs of Long-Term Survivors

September 24th, 2018|Hot Topics, News|

Sunday, September 23, 2018 -- Lung Cancer Alliance's Director of Support Initiatives, Maureen Rigney, LICSW presented findings from a survey done on long-term lung cancer survivors at the official press conference at the 19th Annual World Conference on Lung Cancer in Toronto, Canada. Online survey data showed lung cancer survivors [...]

LCA’s Research Showcased on a World Stage

September 18th, 2018|Hot Topics, News|

The Lung Cancer Alliance team is heading to IASLC's World Conference on Lung Cancer (WCLC), Toronto, Canada from September 23-28, 2018 and will be presenting on hot topics in the field of lung cancer including: clinical trials, long-term survivorship, stigma, advocacy and much more! Below are details on our whereabouts [...]

An Unexpected Path

September 11th, 2018|Hot Topics, News|

Shanen M. Sherrer, PhD By Shanen M. Sherrer, PhD Shanen M. Sherrer, PhD, is the Assistant Professor of Biochemistry, Department of Chemistry and Biochemistry, St. Mary’s College of Maryland. We interviewed Dr. Sherrer to find out about her career as a cancer researcher, how attending a Shine [...]

Survey Shows That Despite Gains, Stigma Remains a Problem

September 5th, 2018|Hot Topics, News|

SURVEY SHOWS INCREASED PUBLIC AWARENESS OF LUNG CANCER OVER LAST DECADE Despite Gains, Stigma Remains a Problem; Survivors Continue to Shoulder Blame for Diagnosis Wednesday, September 5, 2018 – Survey results released today by Lung Cancer Alliance (LCA) show that general awareness about lung cancer has improved significantly over the last [...]

First New Treatment Approved for Small Cell Lung Cancer in 20 Years

August 17th, 2018|Hot Topics, News|

Friday, August 17, 2018 – Today the U.S. Food and Drug Administration approved Opdivo (nivolumab), an immunotherapy treatment, for patients with metastatic small cell lung cancer (SCLC) with progression after platinum-based chemotherapy and at least one other line of therapy. Accelerated approval was granted for this therapy due to [...]

Palliative Care: Managing Symptoms and Improving Quality of Life

August 8th, 2018|Hot Topics, News|

We partnered with and Dr. Andrew Esch, MD, MBA, a medical education consultant to the Center to Advance Palliative Care, for a free webinar discussing how to manage symptoms and side effects of lung cancer and improve quality of life through palliative care. Here’s what you need to know! [...]

LCA Advocates for Patient Access to Robotic Radiosurgery (Cyberknife)

August 8th, 2018|Hot Topics|

Last month, Lung Cancer Alliance (LCA) submitted detailed comments to Noridian Healthcare Solutions, a Medicare contractor, regarding the unintended consequences and patient access implications to reductions in healthcare reimbursement for CyberKnife, robotic radiosurgery/stereotactic body radiation. In response to LCA’s comment letter and other stakeholder feedback, Noridian modified their policy [...]

LCA Opens Milestone 10th Anniversary National Advocacy Summit

July 9th, 2018|Hot Topics, News|

More than 120 Advocates from 28 States Bring Their Collective Voice to Washington, DC Washington, DC [July 10, 2018] – Today, Lung Cancer Alliance (LCA) opens the 10th Anniversary National Advocacy Summit in Washington, DC.  Taking place from July 10 –12, the Summit will bring together 120 survivors, loved [...]

LCA Commends GLCC for Recognizing Excellence in Journalism Coverage of Lung Cancer

July 9th, 2018|Hot Topics, News|

Monday, July 9, 2018 - Today, Lung Cancer Alliance (LCA) is proud to acknowledge the Global Lung Cancer Coalition (GLCC) for selecting the winners of the 2017 Global Lung Cancer Coalition Journalism awards. Each year, the GLCC recognizes outstanding journalistic efforts to advance awareness of lung cancer, the number [...]

Lung Cancer Alliance Joins CURE Media Group Strategic Alliance Partnership (SAP) Program

July 2nd, 2018|Hot Topics, News|

Monday, July 2, 2018 - Today, CURE Media Group announced that LCA has joined its Strategic Alliance Partnership (SAP) Program. The SAP Program is designed to facilitate an open exchange of information among trusted peers, with the goal to improve patient care. The content sharing collaboration will empower the [...]

$20M Secured For Federally-Funded Lung Cancer Research

June 28th, 2018|Hot Topics, News|

House Passes Bipartisan Amendment to Increase Funding in FY19 Budget; Restores Funding to FY09 Level Thursday, June 28, 2018 — Today, Lung Cancer Alliance hailed the passage of a bipartisan amendment in the U.S. House of Representatives that secured an additional $6 million to the Department of Defense (DOD) [...]

Host a Shine a Light on Lung Cancer Event this November!

June 26th, 2018|Events, Hot Topics|

It's that time of year again! Time to start planning your Shine a Light on Lung Cancer event! This year marks the 10th Annual Shine a Light on Lung Cancer event! With Shine a Light, healthcare facilities celebrate and remember survivors, caregivers and all individuals who have been impacted by [...]

LCA Supports Research to Treatment Pathways for Small Cell Lung Cancer

June 4th, 2018|Hot Topics, News|

Monday, June 4, 2018 --Today, Lung Cancer Alliance (LCA) is proud to announce Carl M. Gay, MD, PhD as the recipient of the 2018 Conquer Cancer Foundation of ASCO/Lung Cancer Alliance Young Investigator Award (YIA). Through this award, LCA will support Dr. Gay’s research into whether inhibiting DNA repair [...]

LCA Remains Vigilant in Advocating for At-Risk Individuals

May 31st, 2018|Hot Topics, News|

Wednesday, May 30, 2018 – Lung Cancer Alliance (LCA) continues to represent those at risk for lung cancer and has reignited coalition efforts through a partnership with the Society of Thoracic Surgeons (STS) and American College of Radiology (ACR). The coalition submitted recommendations to United States Preventive Services Task [...]

Congress: When Considering Women’s Health, Don’t Forget about Lung Cancer

May 21st, 2018|Hot Topics, News|

An Op-Ed on Women and Lung Cancer recently ran in The Hill, a top policy newspaper and newsite read by national legislators. The opinion piece was co-authored by Laurie Fenton Ambrose, President & CEO of Lung Cancer Alliance and  Bonnie J. Addario, founder and chair of the Bonnie J. Addario Lung Cancer [...]

A Champion for Lung Cancer Screening

May 14th, 2018|Hot Topics, Stories of Hope|

Cecelia Brewington, MD is a board-certified practicing radiologist, radiology administrator and professor who serves as Medical Director of UT Southwestern Medical Center’s CT Lung Cancer Screening Program; a program she helped found. We interviewed Dr. Brewington to find out more about her 25 year career, what she wants people to [...]

A Tribute to Jane Reese-Coulbourne, LCA Honorary Board Member

April 27th, 2018|Hot Topics, News|

Jane Reese-Coulbourne By Laurie Fenton Ambrose, President & CEO of Lung Cancer Alliance My heart is heavy thinking about a world without Jane Reese-Coulbourne – an extraordinary woman, leader, advocate, and friend – who passed this week from cancer. Her death leaves a gaping hole in the [...]

The New Frontier: Immunotherapy Combinations

April 19th, 2018|Hot Topics, News|

At the annual American Association of Cancer Research (AACR) conference, scientists presented new research on what they called “The New Frontier in Lung Cancer” – immunotherapy combinations. The Big Question: Do Combinations Work? If we take the new immunotherapy drugs (like Keytruda, Opdivo, or Tecentriq) that have shown positive [...]

FDA Approves Tagrisso as First-line Treatment for NSCLC

April 19th, 2018|Hot Topics, News|

Thursday, April 19, 2018 – This week the Food and Drug Administration (FDA) approved targeted therapy drug, osimertinib (Tagrisso), as a frontline treatment for patients with non-small cell lung cancer (NSCLC) who have tumors with the EGFR mutations. The approval is based off results from a study showing that [...]

Living For My Dad

April 12th, 2018|Hot Topics|

By Rachel Heimler Richard (second from left), Rachel (third from right) and their family. Today would have been the 14th anniversary since my dad, Richard, was diagnosed with lung cancer. Each year, for the past 14 years, we have woken up to a letter from my dad [...]

Additional $14 Million Secured For Federally-Funded Lung Cancer Research

March 26th, 2018|Hot Topics, News|

Monday, March 26, 2018 — Today, Lung Cancer Alliance is pleased to acknowledge last week’s passage of the Omnibus FY18 Appropriations Bill by Congress. After months of operating under a continuing resolution, The President signed the $1.3 trillion dollar bill that includes increases to federal cancer and health programs [...]

Nat’l Advocacy Summit Registration Open!

March 26th, 2018|Events, Hot Topics, News|

REGISTER TODAY for Lung Cancer Alliance's 10th Anniversary National Advocacy Summit, July 10-12! Don't miss this special opportunity to join fellow lung cancer survivors and advocates in Washington, DC, as we amplify the national call for lung cancer research, early detection and access to high quality of care. At the National Advocacy Summit, you [...]

A Message from the LCA Board Chair – Lung Cancer:  A Women’s Health Imperative  

March 1st, 2018|Hot Topics, News|

By: Cheryl Healton, DrPH - Director of the Global Institute of Public Health, Dean of College of Global Public Health, New York University Lung cancer is the leading cause of cancer death of women both in the United States and around the world. It claims more lives of women [...]


February 22nd, 2018|Hot Topics|

Lung cancer, the leading cancer killer of women, behaves differently in women than men. But we don’t know why. In order to ignite federal government action around this critical issue to advance research breakthroughs, improve quality of life and increase survival for women and the entire lung cancer community, [...]

First Immunotherapy Treatment Approved for Stage III

February 16th, 2018|Hot Topics, News|

Friday, February 16, 2018. Today the Food and Drug Administration (FDA) approved Imfinzi (durvalumab), the first immunotherapy drug for stage III non-small cell lung cancer. This approval is what is called "maintenance" therapy, which is when you take a drug to help prevent cancer from growing or coming back [...]

We Challenge You! Join the Your Cancer Game Plan Challenge!

February 1st, 2018|Hot Topics, News|

We’re excited to announce that we’ve joined Merck on the Your Cancer Game Plan Challenge, a social sharing program that will help us raise funds and continue our support for lung cancer patients, caregivers, healthcare providers and others. And we’d like to challenge YOU to join our team. During [...]

LCA Praises Bipartisan, Bicameral Congressional Leadership on Women’s Health Imperative

January 31st, 2018|Hot Topics, News|

Senators Marco Rubio (R-FL) and Dianne Feinstein (D-CA) and Representatives Frank LoBiondo (R-NJ), Rick Nolan (D-MN), Barbara Comstock (R-VA) and Suzanne Bonamici (D-OR) Bring Priority Focus to Accelerated Research and Screening Services for Women Impacted by Lung Cancer January 30, 2018 – Today, Lung Cancer Alliance (LCA) hailed the reintroduction [...]

How to Ask for Help

January 25th, 2018|Hot Topics|

A lung cancer diagnosis can be overwhelmingly emotional and complicated. To provide support during this confusing period, Lung Cancer Alliance started a national HelpLine dedicated exclusively to lung cancer. Caring, trained support professionals answer calls to help patients, caregivers and loved ones understand their lung cancer diagnosis, available treatment [...]

VA-PALS – Improving Lung Cancer Screening For Our Veterans

January 25th, 2018|Hot Topics, News|

By: Angela Criswell, Senior Manager of Medical Outreach Lung cancer among veterans is a serious issue because they face higher incidence rates of the disease and lower survival rates compared with civilian populations. The disproportionate impact of lung cancer on veterans is due in part to higher smoking prevalence [...]

FDA expands approval of Gilotrif (afatinib) for NSCLC

January 17th, 2018|Hot Topics, News|

Tuesday, January 16, 2018 – The FDA expanded approval of Gilotrif (afatinib), a first-line treatment for patients with non-small cell lung carcinoma (NSCLC) that is epidermal growth factor receptor (EGFR) mutation-positive. Patients with lung cancers with EGFR S768I, L861Q and G719X may now take Gilotrif. Gilotrif, an oral, once-daily [...]

LCA Participates in Inaugural Meeting of National Lung Cancer Roundtable

December 12th, 2017|Hot Topics, News|

Tuesday, December 12, 2017 – Today, Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance (LCA), along with a coalition of leading healthcare professionals, patients, government and non-governmental organizations, is joining the American Cancer Society for the inaugural meeting of the National Lung Cancer Roundtable. The event, taking [...]

Preserve Access to Community-Based Care

December 11th, 2017|News|

With just days remaining in the legislative calendar, Congress could leave town without fixing an error in Medicare reimbursements that could make it difficult for people with lung cancer and Medicare insurance coverage to receive community-based treatments. Lung Cancer Alliance is working alongside the Community Care Access Coalition – [...]

Former Collegiate Athlete and Lung Cancer Survivor Finds New Focus as Patient Advocate

December 7th, 2017|News|

Lung cancer doesn’t discriminate. Regardless of age, gender, athleticism or overall health, lung cancer can impact any one of us. Just ask lung cancer survivor Taylor Bell Duck. In 2005, Taylor Bell Duck graduated high school and expected to play Division 1 soccer. But when she got to college, [...]

FDA Approves and CMS Advances Coverage Decision for Test that Informs Lung Cancer Treatment Decisions

December 1st, 2017|Hot Topics, News|

The Food and Drug Administration has approved the first diagnostic test for cancer-causing mutations in multiple genes at one time in many types of cancer that will help inform treatment options. For patients with lung cancer this means that fewer tests are necessary to determine what drugs are best to [...]

Coping with Fatigue

November 30th, 2017|Hot Topics, News|

This week we held the fourth and final Coping Series webinar of 2017, addressing one of the most common symptoms and side effects experienced by lung cancer patients and survivors: fatigue. Over 90% of cancer patients experience fatigue during treatment and around 35% continue to experience fatigue up to [...]

A Lung Cancer Hero at Home

November 14th, 2017|Hot Topics|

Sheila Ross, a pioneering lung cancer advocate who founded Lung Cancer Alliance’s presence on Capitol Hill, was recently profiled by the Annapolis, Maryland-based Capital Gazette. The article traces both Sheila’s cancer journey and the advocacy measures that brought heightened awareness and landmark legislation on low dose CT screening for [...]

FDA Approves First-Line Treatment for NSCLC with ALK Biomarker

November 7th, 2017|Hot Topics, News|

Monday, November 6, 2017 - The United States Food and Drug Administration (FDA) approved Alecensa (alectinib) as a first treatment for advanced non-small cell lung cancer that is positive for a biomarker called ALK.  Alecensa was already approved for ALK+ lung cancer that was resistant to other ALK-targeted therapies. [...]

LCA Partners with Memorial Sloan Kettering Cancer Center and the New York University School of Medicine on CASTL Initiative

November 6th, 2017|Hot Topics, News|

Monday, November 6, 2017 – Today, Lung Cancer Alliance (LCA) joins the Memorial Sloan Kettering Cancer Center (MSK) and the NYU School of Medicine (NYU) to announce the launch of the Cessation And Screening To Save Lives (CASTL) Initiative. The project, which is supported by funding from the National [...]

In Harvey’s Wake, A Doctor Remembers Houston’s Strength

October 25th, 2017|Events, Hot Topics, Stories of Hope|

By Daniel Gomez, MD, Department of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer CenterDespite the numerous warnings in the week before the storm, I don’t think that many of us grasped how impactful Hurricane Harvey would be.  For me, this profound event surprisingly had many parallels with my [...]

24 Hours of Golf

October 12th, 2017|News|

Curt and his friends at this year's event. By Curt GroebnerIt all started in mid-summer 2008, when my buddy and I were working our summer job at a local golf course and looking for something fun to do. As a couple of crazy college kids seeking a claim to fame, [...]

2017 National Advocacy Recap

October 3rd, 2017|News|

More than 100 lung cancer survivors and advocates united in Washington, DC to ignite change for all those touched by the disease by sharing their personal lung cancer stories with our nation’s leaders at the 9th National Advocacy Summit, which took place on September 27 and 28. Laurie [...]

Story of Hope: Randy Urmstom

September 28th, 2017|Stories of Hope|

I have practiced law in Seattle as of Counsel to Hendricks & Lewis since 1990 and previously worked in legal and engineering positions in the energy, environmental and waste management sectors. I connected with Lung Cancer Alliance (“LCA”) through its predecessor Alliance for Lung Cancer Advocacy Support and Education [...]

Story of Hope: Cecilia Izzo

September 28th, 2017|Stories of Hope|

I am Chair of Lung Cancer Alliance's newly formed Washington State Chapter. An eight year (and counting) lung cancer survivor, I am primarily responsible for LCA's activities in Western Washington, including forging relationships with hospitals and medical professionals, fundraising, and public outreach. I am a regular visitor to both [...]

LCA Funds Research to Identify Pathways to Targeted Therapies

September 28th, 2017|Hot Topics|

Today, Lung Cancer Alliance (LCA) is proud to announce Dr. Robert Smyth, MB, MSc as the recipient of the 2017 Conquer Cancer Foundation (CCF) – Lung Cancer Alliance Young Investigator Award (YIA). Through this award, LCA will support research that examines whether mutations in tumors can be identified through [...]

National Lung Cancer Roundtable Forms to Increase Screening and Reduce Lung Cancer Deaths

September 28th, 2017|Hot Topics|

Lung Cancer Alliance and a coalition of leading professional, government and non-governmental organizations joined the American Cancer Society to announce they will be coming together to form the National Lung Cancer Roundtable to accelerate the nation's efforts to reduce mortality from lung cancer. The group will focus on ensuring [...]

Where’s My Pink Army?

September 28th, 2017|Hot Topics|

By Jenny White Jenny at the White House during the National Advocacy Summit. I was in pure shock when my surgeon told me “it’s lung cancer,” while in recovery after video-assisted thoracic surgery (VATS) that was performed to find out what was growing in the right upper [...]

FDA Approves First Combination of Chemotherapy and Immunotherapy for Lung Cancer Patients

September 28th, 2017|Hot Topics|

Today, the Food and Drug Administration (FDA) approved the first combination of chemotherapy and immunotherapy for patients with lung cancer. Patients with metastatic, nonsquamous, non-small cell lung cancer can now take Keytruda (pembrolizumab) immunotherapy along with chemotherapy (pemetrexed and carboplatin) as a first line of treatment for their lung [...]

Story of Hope: Tom Murphy

September 28th, 2017|Stories of Hope|

Tom Murphy is a lung cancer survivor outside of Baltimore, Maryland. He was diagnosed with stage 1a lung cancer in 2010. This past November, he ran/walked the Philadelphia Half-Marathon with his nurse, Lisa Smith from St. Agnes Hospital. Why did you think you were at risk? First, I had [...]

Easy Ways to Relax Today!

August 15th, 2017|News|

Relaxation Day is today! Who knew?!? What a great excuse to kick back, calm down and do something nice for yourself. When it comes to facing cancer and the process that comes with it, it can be easy to forget how to relax. Taking care of yourself and your [...]

Workout for the Cause

August 3rd, 2017|News|

Mike, his dad and sister during their time in Africa. By Mike Suskin Two things I admired in my father, and I try to exhibit these traits in my own life, were his strong work ethic and an ability to put things into perspective. While he was [...]

Every Day is Parents’ Day

July 18th, 2017|News|

By JoAnn DeCesaris Wellington My father was the type of person you couldn’t miss when he walked in a room. It wasn’t that he was a big “talker” but rather when he did speak it was something you wanted to hear. Geaton A. DeCesaris, Jr. was kind, smart, generous [...]

A Second Chance

July 7th, 2017|Hot Topics|

By Gary Stumpf Gary hooks success. As with many, I accidentally found my lung cancer. Last fall, a persistent cough brought me to the doctor (thanks to my wife’s insistence). A CT scan, followed by a lung biopsy, confirmed I had stage 4 adenocarcinoma. Further testing found [...]

Beat the Heat!

July 5th, 2017|News|

Summer is heating up and that can play a role in cancer treatment side effects. While going through lung cancer treatment, such as chemotherapy, radiation, targeted therapies or surgery, it is important to find ways to escape the heat. Here are some helpful tips to keep you cool in [...]

2,800 Miles to the Summit

June 29th, 2017|News|

Mary and her husband By Rev. Dr. Mary Holder Naegeli Rev. Dr. Mary Naegeli serves as the Associate Chaplain at John Muir Medical Center in California. She is also an almost-four-year lung cancer survivor. She uses her own experience with cancer to help guide and support patients [...]

This One’s For Sunny

June 9th, 2017|News|

Sunny by Deena Cook We met Sonia “Sunny” Janin at the first Lung Cancer Alliance National Advocacy Summit we attended in September 2014. This event changed my life and Sunny was an important part of that change. There were five other women from Maryland in our group; [...]

My Lucky Break!

May 25th, 2017|News|

Dann (center) at Lung Love Run/Walk Portland. By Dann Wonser Eleven years ago, in 2006, I got the luckiest "break" of my life: I broke my ribs. While that may not seem all that lucky, those broken ribs led to an X-Ray, which led to the discovery [...]

Life Lessons From a Nurse

May 4th, 2017|News|

April Plank, DNP By April Plank, DNP, The Center for Lung Cancer Screening and Prevention, Stony Brook Medicine I realized at a young age that I enjoyed working with people.  This rather broad statement could have led me down endless career paths. My decision to choose the [...]

Coping Series: Digestive Problems

May 2nd, 2017|News|

Last week we held the second discussion in our Coping Webinar Series, focused on the most common side effects of lung cancer treatment, digestive problems, including nausea, vomiting, constipation and diarrhea. We sat down with Director of Palliative Care at Carolinas Healthcare System, Niki Koesel ANP, ACHPN, FPCN and [...]

My Purpose, Our Purpose

April 5th, 2017|News|

Ken and Sheila By Ken Wheatley As a caregiver and now widower, lung cancer radically changed the course of my life and my daily existence. I had finally found the most perfect woman. “Soulmate” tends to be an overused word, but in this case it was completely [...]

Survivor Spotlight: Maureen

April 3rd, 2017|News|

Maureen with her daughter on her 21st birthday. In the early spring of 2011 I was on my first 6-mile outdoor run of the season. My hip was really bothering me. Two weeks later my husband insisted that I go see the orthopedist for my, “sports injury.” After several [...]

Survivor Spotlight: Ide

January 12th, 2017|Stories of Hope|

By Ide Mills The day after Thanksgiving in 2010 I saw my internist for discomfort in my throat that I couldn’t clear. She thought allergies, while I thought everything else, BUT cancer. Over the next few months, it became increasingly more difficult to complete a sentence without being short [...]